Financials Genetec Technology

Equities

GENETEC

MYQ0104OO008

Industrial Machinery & Equipment

End-of-day quote BURSA MALAYSIA 06:00:00 2024-07-15 pm EDT 5-day change 1st Jan Change
2.33 MYR -0.85% Intraday chart for Genetec Technology -0.85% -1.27%

Valuation

Fiscal Period: March 2021 2022 2023 2024 2025 2026
Capitalization 1 194 1,719 2,025 1,806 - -
Enterprise Value (EV) 1 194 1,781 1,896 1,806 1,806 1,806
P/E ratio -43.7 x 31.9 x 26.6 x 17.9 x 15.5 x 12.9 x
Yield - - - 0.86% 0.94% 1.12%
Capitalization / Revenue 2 x 7.69 x 6.59 x 4.3 x 3.73 x 3.24 x
EV / Revenue 2 x 7.69 x 6.59 x 4.3 x 3.73 x 3.24 x
EV / EBITDA - 25.6 x 23.3 x 14.6 x 12.3 x 10.4 x
EV / FCF - -16 x 130 x 34.5 x 22.1 x 17.1 x
FCF Yield - -6.27% 0.77% 2.9% 4.53% 5.84%
Price to Book - 11.5 x 5 x 3.58 x 2.99 x 2.53 x
Nbr of stocks (in thousands) 593,311 681,962 750,158 775,131 - -
Reference price 2 0.3269 2.520 2.700 2.330 2.330 2.330
Announcement Date 7/29/21 5/26/22 5/31/23 - - -
1MYR in Million2MYR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2021 2022 2023 2024 2025 2026
Net sales 1 97.08 223.6 307.4 419.9 484.7 557.5
EBITDA 1 - 67.2 86.87 123.9 146.3 174.3
EBIT 1 - 63.93 83.32 112.1 131.8 158.5
Operating Margin - 28.59% 27.1% 26.7% 27.19% 28.43%
Earnings before Tax (EBT) 1 - 62.29 80.3 110.5 131.3 159.5
Net income 1 - 56.4 73.4 100.2 109.1 131.3
Net margin - 25.23% 23.88% 23.86% 22.51% 23.55%
EPS 2 -0.007480 0.0790 0.1015 0.1300 0.1500 0.1800
Free Cash Flow 1 - -107.7 15.58 52.4 81.8 105.4
FCF margin - -48.19% 5.07% 12.48% 16.88% 18.91%
FCF Conversion (EBITDA) - - 17.93% 42.29% 55.91% 60.47%
FCF Conversion (Net income) - - 21.22% 52.3% 74.98% 80.27%
Dividend per Share 2 - - - 0.0200 0.0220 0.0260
Announcement Date 7/29/21 5/26/22 5/31/23 - - -
1MYR in Million2MYR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2024 Q3
Net sales 1 70.47
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 16.84
Net margin 23.9%
EPS 2 2.180
Dividend per Share -
Announcement Date 5/28/24
1MYR in Million2MYR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2021 2022 2023 2024 2025 2026
Net Debt - 62.6 - - - -
Net Cash position - - 130 - - -
Leverage (Debt/EBITDA) - 0.932 x - - - -
Free Cash Flow 1 - -108 15.6 52.4 81.8 105
ROE (net income / shareholders' equity) - 49% 26.4% 23.2% 20.2% -
ROA (Net income/ Total Assets) - 27% 18.1% - - -
Assets 1 - 209.3 405.7 - - -
Book Value Per Share 2 - 0.2200 0.5400 0.6500 0.7800 0.9200
Cash Flow per Share - -0.1400 0.1300 - - -
Capex - 8.13 76.8 - - -
Capex / Sales - 3.64% 24.98% - - -
Announcement Date 7/29/21 5/26/22 5/31/23 - - -
1MYR in Million2MYR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.33 MYR
Average target price
4.05 MYR
Spread / Average Target
+73.82%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GENETEC Stock
  4. Financials Genetec Technology